Trademark: 79336403
Word
CUVUE ORPHALAN
Status Date
Tuesday, December 20, 2022
Registration Number
6927021
Registration Date
Tuesday, December 20, 2022
Filing Date
Tuesday, November 30, 2021
Published for Opposition
Tuesday, October 4, 2022
5 Pharmaceutical preparations for the treatment of Wilson's disease; pharmaceutical products for the treatment of Wilson's disease; chemical preparations for medical purposes, namely, for treatment of Wilson's disease; chemical preparations for pharmaceutical purposes, namely, for treatment of Wilson's disease; medicinal substances, namely, therapeutic medication for the treatment of Wilson's disease; medicinal preparations for the treatment of Wilson's disease; chemical preparations for medical or pharmaceutical use for the treatment of Wilson's disease; pharmaceutical products and medicines for the treatment of Wilson's disease; pharmaceutical preparations for the diagnosis of Wilson disease; pharmaceutical and chemical preparations for medical purposes, namely, for copper level measurement for the diagnosis and treatment of Wilson's disease; chemical reagents for medical purposes; chemical reagents for medical diagnostic purposes in patients with Wilson's disease; pre-filled syringes sold filled with pharmaceuticals for medical purposes for the diagnosis and treatment of Wilson's disease; medicated serums for diagnostic purposes, specifically, for the treatment of Wilson's disease; biological preparations for medical purposes for the treatment of Wilson's disease, specifically, for the measurement of copper in patients with Wilson's disease; chemical preparations for medical purposes for the measurement of copper in patients with Wilson's disease; clinical diagnostic reagents for medical use; diagnostic preparations for medical purposes for treatment of Wilson's disease; medical diagnostic reagents and assays for testing of body fluids to diagnose the level of copper
44 Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services relating to the treatment of persons, namely diagnosis of copper levels in patients with Wilson's disease; medical screening; health care for patients with Wilson's disease; health assessment services care for patients with Wilson's disease; home-visit nursing care; medical services, namely, blood testing services provided by medical laboratories for patients with Wilson's disease; medical clinic services and medical analysis services provided by medical laboratories for diagnostic purposes for patients with Wilson's disease; medical analysis services provided by medical laboratories for diagnostic purposes to measure copper levels in patients with Wilson's disease; medical diagnostic testing, monitoring and reporting services for patients with Wilson's disease; medical testing for diagnostic or treatment purposes in the field of Wilson's disease
The mark consists of the wording "CUVUE", in blue, stacked above the wording "ORPHALAN", in blue. Above the wording "CUVUE" appears a wavy band that is made up of individual brown and gold circles.
The color(s) blue, brown, and gold is/are claimed as a feature of the mark.
Apr 25, 2023
Final Decision Transaction Processed By Ib
Apr 5, 2023
Final Disposition Notice Sent To Ib
Apr 5, 2023
Final Disposition Processed
Mar 20, 2023
Final Disposition Notice Created, To Be Sent To Ib
Dec 20, 2022
Notice Of Registration Confirmation Emailed
Dec 20, 2022
Registered-Principal Register
Oct 4, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 4, 2022
Published For Opposition
Oct 3, 2022
Notification Processed By Ib
Sep 14, 2022
Notification Of Possible Opposition Sent To Ib
Sep 14, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Sep 14, 2022
Notification Of Notice Of Publication E-Mailed
Aug 26, 2022
Approved For Pub - Principal Register
Aug 25, 2022
Teas/Email Correspondence Entered
Aug 25, 2022
Correspondence Received In Law Office
Aug 25, 2022
Teas Response To Office Action Received
Aug 23, 2022
Refusal Processed By Ib
Aug 4, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Aug 4, 2022
Refusal Processed By Mpu
Jul 19, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Jul 18, 2022
Non-Final Action Written
Jul 8, 2022
Assigned To Examiner
Mar 29, 2022
Application Filing Receipt Mailed
Mar 25, 2022
New Application Office Supplied Data Entered
Mar 24, 2022
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
